What is Imbria Pharmaceuticals worth?
$131.7Mlast known valuation
Imbria Pharmaceuticals last raised $66.7M in its Later Stage VC (Series B) (Dec 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Imbria Pharmaceuticals
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC (Series B) | $66.7M | ▮ | ▮ |
| Jun 2020 | Early Stage VC | $40.7M | ▮ | ▮ |
How Imbria Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Imbria Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Imbria Pharmaceuticals worth?
- Imbria Pharmaceuticals's last known valuation is $131.7M.
- How much has Imbria Pharmaceuticals raised?
- Imbria Pharmaceuticals has raised $151.9M in total funding across 2 recorded rounds.
- When did Imbria Pharmaceuticals last raise?
- Imbria Pharmaceuticals last raised in Dec 2025 (Later Stage VC (Series B)), raising $66.7M.